Gapping up
In reaction to earnings/guidance:
- PLBY +12.6%, WGO +5.9%, BNGO +5.6%, HOME +2.6%, ACCD +2.3% (also convertible notes offering), AIR +1.5%, FSS +0.8%, RILY +0.7%, ADBE +0.4% (also CFO to retire)
Other news:
- DLPN +79.7% (HOFV signs partnership with DLPN for non-fungible tokens offerings)
- HOFV +76.4% (HOFV signs partnership with DLPN for non-fungible tokens offerings)
- ALYA +55.5% (acquires R3D Conseil, a firm that specializes in digital solutions, for CAD 76 mln)
- BCLI +26.3% (announce data from the Company's Phase 2 trial evaluating three repeated administrations of NurOwn as a treatment for progressive multiple sclerosis) KLDO +16.5% (reports positive results from non-ind study demonstrating a reduction in COVID-19 related healthcare utilization and recovery time in patients with mild-to-moderate COVID-19 and one or more comorbidity)
- IPHI +7% (MRVL's proposed acquisition of IPHI gets Chinese regulatory approval)
- MYOV +6.8% (Myovant Sciences and Pfizer (PFE) report Phase 3 LIBERTY study of once-daily Relugolix combination therapy in women with uterine fibroids met primary endpoint)
- AMAT +4.4% (semi equipment names moving higher on Intel building two new plants)
- KLAC +4.3% (semi equipment names moving higher on Intel building two new plants)
- LRCX +3.8% (semi equipment names moving higher on Intel building two new plants)
- INTC +3.4% (announces "IDM 2.0" strategy; to invest $20 bln on two new factories in Arizona; also expects Q1 results to be better than prior guidance but guides FY21 EPS below consensus)
- DVAX +3.1% (reports first patient dosed in global Phase 2/3 clinical trial for Adjuvanted S-Trimer COVID-19 vaccine candidate)
- KZIA +2.3% (releases Chairman letter to shareholders)
- KBR +2.2% (awarded contracts for revamping two ammonia plants by PJSC Acron Group, Novgorod, Russia)
- AVEO +2.1% (prices offering of 6 mln shares of common stock at $8.00 per share)
- MRVL +1.5% (MRVL's proposed acquisition of IPHI gets Chinese regulatory approval)
- MOS +1.4% (announces a strategic collaboration with AgBiome)
- LH +1.3% (provides business update; announces review of co's structure and capital allocation strategy)
- KLIC +1% (semi equipment names moving higher on Intel building two new plants)
Analyst comments:
- CLMT +6.1% (upgraded to Overweight from Equal Weight at Wells Fargo)
- NEXT +5.8% (upgraded to Outperform from Neutral at Credit Suisse)
- AA +4.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- MTDR +3.1% (upgraded to Buy from Neutral at MKM Partners)
- CLR +2.6% (upgraded to Buy from Neutral at MKM Partners)
- NET +2.3% (upgraded to Buy from Hold at Truist)
- ZS +2.2% (upgraded to Buy from Hold at Truist)
- BK +2% (upgraded to Buy from Underperform at BofA Securities)
- EL +1.9% (upgraded to Overweight from Equal Weight at Wells Fargo)
- CME +1.5% (upgraded to Buy from Neutral at BofA Securities)